Puma Biotechnology, Inc. (PBYI) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	231.2M	228.4M	230.5M	235.6M	228.0M
Cost of Revenue	58.2M	58.2M	64.4M	62.7M	55.1M
Gross Profit	173.0M	170.2M	166.1M	173.0M	172.9M
Operating Expenses
R&D Expense	71.4M	62.1M	54.9M	50.4M	52.2M
SG&A Expense	71.4M	71.2M	80.2M	89.3M	90.0M
General & Admin Expense	71.4M	71.2M	80.7M	88.4M	90.0M
Selling & Marketing Expense	—	—	(519.0K)	881.0K	—
Other Expenses	(213.0K)	(362.0K)	—	625.0K	7.0M
Total Operating Expenses	142.6M	132.9M	135.1M	140.3M	149.2M
Cost and Expenses	200.8M	191.1M	199.5M	203.0M	204.3M
Operating Income (EBIT)	30.4M	37.3M	31.0M	32.6M	23.7M
Non-Operating
Interest Income	3.9M	4.1M	4.7M	2.6M	813.0K
Interest Expense	3.5M	6.6M	12.5M	13.3M	11.6M
Net Interest Income	335.0K	(2.5M)	(7.7M)	(10.7M)	(10.8M)
Other Non-Op Income/Expense	732.0K	(1.5M)	(6.9M)	(10.0M)	(23.3M)
Non-Operating Income (excl Interest)	(4.3M)	(5.1M)	(5.6M)	(3.4M)	11.7M
EBT (Pre-Tax Income)	31.2M	35.8M	24.1M	22.7M	457.0K
Income Tax Expense	4.5M	4.7M	(6.2M)	1.1M	455.0K
Bottom Line
Net Income	26.7M	31.1M	30.3M	21.6M	2.0K
Earnings from Cont. Ops	26.7M	31.1M	30.3M	21.6M	2.0K
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	26.7M	31.1M	30.3M	21.6M	2.0K
Per Share
Basic EPS	$0.54	$0.62	$0.62	$0.46	$0.02
Diluted EPS	$0.52	$0.61	$0.62	$0.45	$0.02
Revenue Per Share	$4.54	$4.57	$4.74	$5.00	$5.10
Shares
Basic Shares Outstanding	50.9M	50.0M	48.6M	47.1M	44.7M
Diluted Shares Outstanding	52.6M	50.7M	49.1M	47.6M	44.9M
Profitability Metrics
EBITDA	47.7M	53.3M	48.1M	47.5M	21.9M
D&A	13.0M	10.9M	11.5M	11.5M	9.8M
EBIT	34.7M	42.4M	36.6M	36.0M	12.0M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026